Cargando…

Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors

INTRODUCTION: Cognitive symptoms persisting beyond 3 months following COVID-19 present a considerable disease burden. We aimed to establish a domain-specific cognitive profile of post-COVID-19 syndrome (PCS). We examined the deficits’ persistence, relationships with subjective cognitive complaints,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozik, Valeska, Reuken, Philipp, Utech, Isabelle, Gramlich, Judith, Stallmach, Zoe, Demeyere, Nele, Rakers, Florian, Schwab, Matthias, Stallmach, Andreas, Finke, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616256/
https://www.ncbi.nlm.nih.gov/pubmed/37915528
http://dx.doi.org/10.3389/fpsyg.2023.1233144
_version_ 1785129353987751936
author Kozik, Valeska
Reuken, Philipp
Utech, Isabelle
Gramlich, Judith
Stallmach, Zoe
Demeyere, Nele
Rakers, Florian
Schwab, Matthias
Stallmach, Andreas
Finke, Kathrin
author_facet Kozik, Valeska
Reuken, Philipp
Utech, Isabelle
Gramlich, Judith
Stallmach, Zoe
Demeyere, Nele
Rakers, Florian
Schwab, Matthias
Stallmach, Andreas
Finke, Kathrin
author_sort Kozik, Valeska
collection PubMed
description INTRODUCTION: Cognitive symptoms persisting beyond 3 months following COVID-19 present a considerable disease burden. We aimed to establish a domain-specific cognitive profile of post-COVID-19 syndrome (PCS). We examined the deficits’ persistence, relationships with subjective cognitive complaints, and clinical variables, to identify the most relevant cognitive deficits and their predictors. METHODS: This cross-sectional study examined cognitive performance and patient-reported and clinical predictors of cognitive deficits in PCS patients (n = 282) and socio-demographically comparable healthy controls (n = 52). RESULTS: On the Oxford Cognitive Screen-Plus, the patient group scored significantly lower in delayed verbal memory, attention, and executive functioning than the healthy group. In each affected domain, 10 to 20% of patients performed more than 1.5 SD below the control mean. Delayed memory was particularly affected, with a small effect of hospitalization and age. Attention scores were predicted by hospitalization and fatigue. DISCUSSION: Thus, PCS is associated with long-term cognitive dysfunction, particularly in delayed memory, attention, and executive functioning. Memory deficits seem to be of particular relevance to patients’ experience of subjective impairment. Hospitalization, fatigue, and age seem to predict cognitive deficits, while time since infection, depression, and pre-existing conditions do not.
format Online
Article
Text
id pubmed-10616256
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106162562023-11-01 Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors Kozik, Valeska Reuken, Philipp Utech, Isabelle Gramlich, Judith Stallmach, Zoe Demeyere, Nele Rakers, Florian Schwab, Matthias Stallmach, Andreas Finke, Kathrin Front Psychol Psychology INTRODUCTION: Cognitive symptoms persisting beyond 3 months following COVID-19 present a considerable disease burden. We aimed to establish a domain-specific cognitive profile of post-COVID-19 syndrome (PCS). We examined the deficits’ persistence, relationships with subjective cognitive complaints, and clinical variables, to identify the most relevant cognitive deficits and their predictors. METHODS: This cross-sectional study examined cognitive performance and patient-reported and clinical predictors of cognitive deficits in PCS patients (n = 282) and socio-demographically comparable healthy controls (n = 52). RESULTS: On the Oxford Cognitive Screen-Plus, the patient group scored significantly lower in delayed verbal memory, attention, and executive functioning than the healthy group. In each affected domain, 10 to 20% of patients performed more than 1.5 SD below the control mean. Delayed memory was particularly affected, with a small effect of hospitalization and age. Attention scores were predicted by hospitalization and fatigue. DISCUSSION: Thus, PCS is associated with long-term cognitive dysfunction, particularly in delayed memory, attention, and executive functioning. Memory deficits seem to be of particular relevance to patients’ experience of subjective impairment. Hospitalization, fatigue, and age seem to predict cognitive deficits, while time since infection, depression, and pre-existing conditions do not. Frontiers Media S.A. 2023-10-17 /pmc/articles/PMC10616256/ /pubmed/37915528 http://dx.doi.org/10.3389/fpsyg.2023.1233144 Text en Copyright © 2023 Kozik, Reuken, Utech, Gramlich, Stallmach, Demeyere, Rakers, Schwab, Stallmach and Finke. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Kozik, Valeska
Reuken, Philipp
Utech, Isabelle
Gramlich, Judith
Stallmach, Zoe
Demeyere, Nele
Rakers, Florian
Schwab, Matthias
Stallmach, Andreas
Finke, Kathrin
Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title_full Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title_fullStr Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title_full_unstemmed Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title_short Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
title_sort characterization of neurocognitive deficits in patients with post-covid-19 syndrome: persistence, patients’ complaints, and clinical predictors
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616256/
https://www.ncbi.nlm.nih.gov/pubmed/37915528
http://dx.doi.org/10.3389/fpsyg.2023.1233144
work_keys_str_mv AT kozikvaleska characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT reukenphilipp characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT utechisabelle characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT gramlichjudith characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT stallmachzoe characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT demeyerenele characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT rakersflorian characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT schwabmatthias characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT stallmachandreas characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors
AT finkekathrin characterizationofneurocognitivedeficitsinpatientswithpostcovid19syndromepersistencepatientscomplaintsandclinicalpredictors